Key Takeaways

  • The Trimbos Institute found that recently submitted Trump-shaped pills contained high concentrations of PMMA, a potentially lethal substance.
  • PMMA can take effect more slowly than MDMA, increasing the risk that users take additional pills and overdose.
  • The warning highlights the business and public-safety value of the Netherlands’ drug-testing network, particularly during festivals and nightlife events.

The Trimbos Institute has issued a “Red Alert” in the Netherlands after drug-testing centers received potentially lethal ecstasy pills shaped like the head of U.S. President Donald Trump.

Several of the tablets were recently submitted through the country’s network of testing facilities, which allows people to have illicit drugs analyzed before consuming them. The Trimbos Institute responded with an unusually direct warning: “Absolutely do not use these pills.”

Testing found a high concentration of PMMA, or para-methoxymethamfetamine. The synthetic substance resembles MDMA, the psychoactive ingredient users generally expect in ecstasy, but its delayed effects create a particular danger. Someone who feels little after taking one pill may assume it is weak and consume another. By the time the PMMA takes effect, the accumulated dose can cause severe toxicity.

The consequences can include dangerous overheating and, in some cases, death. That threat is especially relevant in crowded clubs and music festivals, where prolonged dancing, warm indoor spaces and limited opportunities to cool down may compound the physiological risks associated with stimulant use.

Visually, the pills are distinctive. They depict Trump’s head on one side, while “NL” and “Trump” appear on the reverse, separated by a vertical line. Images released with the warning showed green and yellow versions.

Still, appearance is not a reliable safety indicator. Illicit manufacturers can reuse shapes, colors and logos while changing a tablet’s chemical composition or dosage. Two pills that look identical may contain very different substances. That uncertainty is one reason the Dutch Drugs Information and Monitoring System combines laboratory testing with market surveillance and public alerts.

Novelty branding is not just decoration in the illicit-drug market. Recognizable political figures, commercial logos and pop-culture symbols can make tablets memorable and potentially more attractive to buyers. But branding also creates a false sense of product consistency. There is no regulated manufacturing process behind the stamp.

A spokesperson for the Trimbos Institute told The Associated Press that the institute had not received reports of serious illness or deaths linked to the tablets. “We do not know of any victims where PMMA was found in their blood,” the spokesperson said.

That absence of confirmed victims does not reduce the urgency of the alert. It may instead show why rapid testing and targeted communication matter. A warning distributed before a cluster of hospitalizations can interrupt circulation, encourage users to discard suspect tablets and give event organizers and medical teams a clearer idea of what may be entering the market.

Producing, selling and using ecstasy remains illegal in the Netherlands. Yet use is widespread, particularly in nightlife and festival settings. A 2024 government report indicated widespread consumption of the drug throughout the year. The Government of the Netherlands combines prohibition and enforcement with public-health measures intended to limit harm.

That policy can look contradictory from the outside. Why provide testing for an illegal product? Dutch authorities and health organizations generally treat testing as an early-warning capability rather than an endorsement of consumption. Submitted samples can reveal unexpected compounds, unusually strong doses and shifts in the illicit supply before those developments become a larger medical emergency.

For festival operators, venue owners and nightlife businesses, the episode is a reminder that drug-related risk extends beyond security screening. Staff training, access to drinking water, temperature management, on-site medical capacity and clear escalation procedures can all affect the outcome when a visitor becomes ill. Communications teams also need a way to distribute credible warnings quickly without turning dangerous tablets into promotional curiosities.

Trump-shaped tablets are not new. German police seized thousands of orange pills with a similar design in 2017. The recurrence shows how molds and branding concepts can persist across borders and reappear years later with different ingredients.

The immediate message from the Trimbos Institute is simpler than the broader policy debate. Anyone encountering the green or yellow Trump-shaped pills marked “NL” and “Trump” should not consume them. For health authorities and businesses operating around nightlife, the alert also demonstrates how chemical testing, market monitoring and fast public communication can work together before a distinctive product becomes a deadly trend.